The risk may be caused by the potential presence of N-nitrosodimethylamine (NDMA) contamination in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic and other toxic effects, risk to health and life.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from any batch. Patients who have this medicine should stop using it, return the packs to a pharmacy, and consult a doctor to choose alternative treatment.
Suspension of distribution throughout the country of all batches of the medicinal product Ranigast (Ranifidinum) 150 mg, film-coated tablets, and granting the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related